Table 3. Clinical characteristics of gastric adenocarcinoma patients in the training group and test group.
| Characteristics | Training Group (%) | Test Group (%) | p value |
| Age(years) | 0.090 | ||
| <60 | 59 (51.3) | 61 (62.9) | |
| ≧60 | 56 (48.7) | 36 (37.1) | |
| Gender | 0.496 | ||
| Male | 74 (64.3) | 58 (59.8) | |
| Female | 41 (35.7) | 39 (40.2) | |
| Tumor size(cm) | 0.737 | ||
| <4 | 32 (27.8) | 25 (25.8) | |
| ≧4 | 83 (72.2) | 72 (74.2) | |
| Depth of invasion | 0.675 | ||
| T1 | 5 (4.4) | 3 (3.1) | |
| T2 | 12 (10.4) | 6 (6.2) | |
| T3 | 25 (21.7) | 23 (23.7) | |
| T4 | 73 (63.5) | 65 (67.0) | |
| Lymph node metastasis | 0.734 | ||
| N0 | 37 (32.2) | 25 (25.8) | |
| N1 | 20 (17.4) | 21 (21.6) | |
| N2 | 24 (20.9) | 21 (21.6) | |
| N3 | 34 (29.5) | 30 (31.0) | |
| Distance metastasis | 0.075 | ||
| M0 | 107 (93.0) | 83 (85.6) | |
| M1 | 8 (7.0) | 14 (14.4) | |
| UICC staging | 0.366 | ||
| I | 13 (11.3) | 7 (7.2) | |
| II | 30 (26.1) | 23 (23.7) | |
| III | 63 (54.8) | 53 (54.7) | |
| IV | 9 (7.8) | 14 (14.4) | |
| Histologic grade | 0.046 | ||
| Well | 27 (23.5) | 14 (14.4) | |
| Moderate | 29 (25.2) | 17 (17.5) | |
| Poor | 59 (51.3) | 66 (68.1) | |
| Death | 0.573 | ||
| No | 59 (51.3) | 46 (47.4) | |
| Yes | 56 (48.7) | 51 (52.6) |